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Abstract 
Cellular exposure to hypoxia results in altered gene expression in a range of physiologic and 
pathophysiologic states. Discrete cohorts of genes can be either up- or down-regulated in response 
to hypoxia. While the Hypoxia-Inducible Factor (HIF) is the primary driver of hypoxia-induced 
adaptive gene expression, less is known about the signalling mechanisms regulating hypoxia-
dependent gene repression. Using RNA-seq, we demonstrate that equivalent numbers of genes are 
induced and repressed in human embryonic kidney (HEK293) cells. We demonstrate that nuclear 
localization of the Repressor Element 1-Silencing Transcription factor (REST) is induced in 
hypoxia and that REST is responsible for regulating approximately 20% of the hypoxia-repressed 
genes. Using chromatin immunoprecipitation assays we demonstrate that REST-dependent gene 
repression is at least in part mediated by direct binding to the promoters of target genes. Based on 
these data, we propose that REST is a key mediator of gene repression in hypoxia . 
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Introduction 
Hypoxia is a feature of a range of physiological and pathophysiological conditions including 
embryonic development, exercise, cancer, ischemia and inflammation 1. Throughout evolution, 
adaptive pathways have developed to help an organism cope with hypoxia. The best-described 
transcriptional adaptive response in cells is mediated by the hypoxia inducible factor (HIF) 
signalling pathway, which up-regulates genes which restore oxygen and energy homeostasis 2-4. In 
normoxia, HIFα is hydroxylated by the prolyl-hydroxylase domain (PHD) family of dioxygenases 
targeting it for ubiquitylation by the von Hipple Lindau E3 ligase complex and subsequent 
proteosomal degradation 5. This process is reversed in hypoxia and HIFα is stabilized, dimerises 
with HIFβ and binds to hypoxia response elements (HRE) in the regulatory regions of target genes 
6. HIF drives an adaptive response to hypoxia by promoting the expression of genes that regulate 
erythropoiesis, angiogenesis and glycolysis 6. However in cancer, HIF signalling can be 
maladaptive and contribute to tumour survival 7. 
 
Microarray studies of mammalian cells exposed to hypoxia have shown that approximately the 
same numbers of genes are repressed and induced 2,3,8. While HIF has been described as a master 
regulator of gene expression in hypoxia, a significant number of other transcription factors are also 
hypoxia-sensitive and control HIF-independent gene expression 9. Microarray data combined with 
siRNA against HIF-1/-2 indicate that there are HIF-dependent and HIF-independent genes which 
are differentially expressed in hypoxia 2. ChIP-seq and microarray data indicate that while HIF is 
enriched in the promoters of genes induced in a HIF-dependent way, it is not enriched in the 
promoters of genes that are repressed in hypoxia, thus indicating the presence of HIF-independent 
and/or indirectly HIF-dependent mechanisms governing gene repression in hypoxia 10. While HIF 
is well known to regulate gene induction 2-4, the mechanisms underpinning transcriptional 
repression of genes in hypoxia remain poorly understood and is the topic of the current study 8,11. 
Transcriptional repressors are a large and diverse group of proteins 12. Mechanistically repressors 
can act by inhibiting the basal transcription machinery, ablation of activator function and 
remodelling of chromatin. They can be further classified into DNA-binding proteins (Class I) like 
Krüppel zinc fingers, proteins that bind DNA-binding proteins (Class II) such as the DNA-
methyltransferase Dnmt3, or proteins that target activators, reducing their activity, such as IκB that 
sequesters NFκB in the cytosol 12.  
 
The Repressor Element 1-Silencing Transcription Factor (REST) is a C2H2- or Krüppel-type zinc 
finger, one of the largest classes of transcription factors in humans 13. It binds to the 21 base pair 
Repressor Element 1 (RE1) on the promoter of target genes and inhibits transcription by regulating 
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chromatin structure or by inhibiting the basal transcriptional machinery 14. Proteosomal REST 
degradation is induced during neuronal differentiation, resulting in the promotion of the expression 
of the genes which confer the unique neuronal phenotype 14,15. Thus, REST was initially regarded 
as a master regulator of neurogenesis and as the first example of a vertebrate transcription silencer 
protein that regulates a large repertoire of cell type-specific genes 16. However, REST has since 
being shown to be implicated in the regulation of non-neuronal biological processes in a variety of 
cell types, including cardiac myocytes, immune, vascular and tumour cells 15,17-19. In the aging 
human brain, REST is induced to protect against oxidative stress and brain neurodegeneration 20. 
Of particular interest for our study, ischemia and/or oxygen-glucose deprivation have previously 
been shown to induce REST nuclear protein and mRNA 21,22 and to modulate the expression of 
target genes 21. Furthermore, we have recently shown that REST represses the HIF-1α mRNA 
expression and contributes to the resolution of the HIF response during prolonged hypoxia 23. This 
led us to explore the global response of REST to cellular hypoxia, with the aim of developing our 
understanding of the signalling mechanisms underpinning hypoxia-dependent transcriptional 
repression.  
 
Using an unbiased, high-throughput approach combined with biochemical analysis, we 
demonstrate that REST accumulates in the nucleus of cells exposed to hypoxia and acts as a key 
repressor of the hypoxic transcriptome, regulating approximately 20% of the hypoxia-repressed 
genes. Furthermore, hypoxia leads to a change in the target gene repertoire of REST, from the 
repression of neuronal genes in normoxic/basal conditions, to the repression of metabolic, cell 
cycle and proliferation related genes in hypoxia. Together these findings indicate a previously 
unknown key role for the tumour suppressor REST in hypoxic signalling.  
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Results   
 
High-throughput analysis of the transcriptional responses to hypoxia. 
Previous microarray-based transcriptomic analysis of changes in global mRNA expression in 
response to hypoxia revealed that down-regulated genes reach their maximal repression following 
prolonged hypoxic exposure, while induced transcripts generally reach their maximum induction 
at earlier time-points 8. Here we used human embryonic kidney (HEK293) cells exposed to 
normoxia or hypoxia for 24 hours as a cell model to investigate the processes associated with gene 
repression. High-throughput sequencing of poly(A)+ RNA (RNA-Seq) was performed on samples 
collected and transcript analysis revealed the presence of almost 2000 genes that were 
differentially expressed in hypoxia, with similar numbers of genes being induced (green; 851) and 
repressed (red; 1013) (Figure 1A). These data are quantitatively consistent with previously 
published transcriptomic studies of human cells exposed to hypoxia 2,3,8. Importantly, cohorts of 
well-characterized hypoxia-induced genes were up regulated including LDHA, HK2, SLC2A1, 
EGLN1 and BNIP3 (Figure 1B). Furthermore, a number of previously characterized hypoxia-
repressed genes were present in the down-regulated cohort including RRS1 (involved in ribosome 
biogenesis) and MTHFD1 (involved in de novo purine synthesis) (Figure 1B) 3,8. Therefore, 
hypoxia had comparable effects on global gene induction and repression in HEK293 cells.  
 
Using PANTHER ontological analysis, we classified hypoxia-induced and repressed genes 
according to gene ontology (http://www.pantherdb.org/). Our analysis revealed that hypoxia-
induced and repressed genes could be associated with either similar or distinct processes (Figure 
1C, Figures 1D, S1). For example, the glycolytic pathway, known previously to be induced in 
response to hypoxia 1, was identified only on the list of hypoxia-induced metabolic pathways 
(Figures 1C, S1G) while genes encoding proteins associated with intercellular junctions were 
identified only in the hypoxia-repressed gene cohort (Figure S1F). Although both induced and 
repressed gene cohorts included genes involved in the regulation of transcription, metabolism and 
development, only the repressed cohort contained an overrepresentation of genes involved in 
mRNA processing and splicing (Figures 1D). Taken together, these results indicate that hypoxia 
alters the expression of an equivalent number of increased and decreased genes which have both 
common and distinct roles in regulating cell responses.  
 
REST is a hypoxia sensitive transcription factor 
We next focused on possible molecular mechanisms underpinning the repression of gene 
transcription in hypoxia. REST was initially identified as a regulator of neuronal gene expression, 
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but was subsequently shown to have non-neuronal roles 17-19. Using publically available 
microarray datasets, we confirm that REST is extensively expressed in multiple tissue types and 
cell lines, being highly expressed in HEK293 cells used in this study (Figure 2A and S2). HEK293 
cells have been instrumental for the discovery of various aspects of REST biology: transcriptional 
networks 24, phosphorylation and the proteasome system 25 and regulation of HIF-1α in hypoxia 23. 
Similar levels of REST could be detected in the nucleus and cytoplasm of normoxic HEK293 cells 
(Figure S3). In response to hypoxia, there was a more pronounced increase in REST levels in the 
nuclear (Figures 2B, C) than in either the cytoplasmic (Figures 2D, E) or whole cell extracts 
(Figure 2F,G), suggesting nuclear accumulation as the major response of REST to hypoxia. This 
nuclear accumulation was also observed in MCF10A (Figure S4). We investigated the effect of re-
oxygenation on nuclear REST levels, and found that accumulation in hypoxia was reversible 
within one hour of re-oxygenation (Figure 2H), strongly supporting an oxygen-regulated post-
translational control mechanism of REST cellular localization from the cytoplasm to the nucleus 
and back. 
The increase in nuclear REST protein was associated with an increase in REST-dependent 
repressor activity, as measured using by a repressor element-1 (RE1)-luciferase assay developed to 
measure REST transcriptional activity (Figures 2I and S5). REST mRNA expression during 
hypoxic exposure was modestly and transiently increased, and was statistically significant only at 
the 2 hours time point (Figure 2J).   
To assess the effect of hypoxia on REST protein stability, HEK293 cells were exposed to 24 hours 
of either normoxia (21 % oxygen) or hypoxia (1 % oxygen), followed by cycloheximide treatment 
in normoxia and protein stability was monitored by western blot. REST displayed a long half-life 
that was not increased by hypoxia (Figures S6A, B). In contrast, HIF-1α in the same cells 
exhibited a short half-life, with hypoxia-stabilized HIF-1α being completely degraded within 1 
hour of culture in normoxia (Figure S6C). β-Actin exhibited a long half-life that was also not 
affected by hypoxia (Figure S6D). 
 
Taken together, these results suggest that hypoxia leads to REST nuclear translocation, through a 
post-translational oxygen regulated mechanism, with a modest increase in transcription and, unlike 
HIF, independent of altered protein stability.  
 
Role of REST in basal gene expression in hypoxia 
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The observation that nuclear REST expression and activity are increased led us to hypothesize that 
REST may play a broad role in regulating gene repression in hypoxia. To address this, we 
performed RNA-Seq analysis of hypoxic cells in the presence of scrambled or REST-specific 
siRNA (Figure 3A). An overview of the different steps performed to identify differentially 
expressed genes is shown in Figure S7A. All quality control checks are shown in Figures S7B-E 
and S8. As described earlier (Figure 1B), a cohort of known hypoxia-inducible genes served as 
positive experimental controls. REST-RNAi treatment led to a decrease in REST mRNA (Figures 
3B and S9A) and protein expression (Figures S9B, S9C) and a resultant increase in a number of 
previously identified REST target genes 24,26 in 21% oxygen (Figure 3C), thus validating the 
effectiveness of the REST-RNAi knockdown. 
Among the genes whose basal expression was reduced in hypoxia (1013 genes represented by blue 
and red dots in Figure 3D), 201 (~20%) were found to be REST-Dependent (red dots in Figure 
3D), i.e. they were not significantly repressed by hypoxia when REST was silenced (Figure 3E, 
Supplemental Table S1). On the other hand, 812 genes repressed in hypoxia were found to be 
REST-Independent, suggesting alternative gene regulation (Supplemental Table S1). An 
ontological and clustering analysis of the hypoxia-repressed genes showed that metabolic 
processes and other energy demanding processes including transcription, proliferation and cell 
cycle were heavily over-represented in the cohort repressed in a hypoxia and REST-Dependent 
manner (Figure 3F and Supplemental Table S2). Analysis of cell death in hypoxic cells treated 
with RNAi targeting REST did not reveal any effect of REST on cell death (Figure S10). 
Altogether, these data indicate that REST is an important transcriptional repressor in hypoxia, 
whose major function is beyond the control of cell survival in hypoxia. 
 
REST regulates specific gene cohorts in normoxia and hypoxia by direct binding to gene 
promoters 
Comparison of the REST-dependent genes repressed in hypoxia to the REST-Dependent genes 
repressed in normoxia revealed a limited overlap (5 genes, Figure 4A and Supplemental Table S3). 
Ontological analysis revealed well characterised neuronal genes regulated by REST in normoxia 
(Figures 4A black circle and 4B). A different subset of genes were found for REST-repressed 
genes in hypoxia (Figures 4A red circle and 4C), with ontological analysis showing an enrichment 
for metabolic and cell adhesion processes (Figure 4A). Among the 10 genes most sensitive to 
REST regulation in hypoxia (Figure 4C), RAB3C (encoding for RAB3C GTPase), is predicted to 
be regulated by REST in normoxia and hypoxia, while CYP1B1 (encoding for cytochrome P450 
1B1) is predicted to be regulated only in hypoxia. Using qRT-PCR we tested and validated these 
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findings (Figures 4D, E). Together, these results indicate that hypoxia leads to the recruitment of 
REST to a largely different set of genes from those regulated by REST in normoxia. We tested a 
further group of 6 genes for their regulation by REST in hypoxia. While we observed a similar 
trend in the rescue of repression by siREST, only 1 gene, GANAB (encoding for the neutral alpha-
glucosidase AB in the glycan metabolism pathway) was significantly de-repressed (Figure S11). 
Overall, we confirmed that 3 out of 8 genes were bona fide REST target genes in hypoxia, from 
which so we could assume a similar percentage of the 201 newly identified REST target genes in 
hypoxia to be similarly genuine (38%, about 75 genes).  
 
In order to test if the REST regulation of hypoxia repressed gene is direct or indirect, we searched 
for the consensus RE1 motif (Figure 5A) in the region from -2 kilobase pairs to +1 kilobase pairs 
from the transcription start site in the cohort of genes repressed by REST in hypoxia. In this 
search, we found high stringency consensus RE1 sites in just 12 genes (Figures 5B, C). This 
indicates that, in the majority of cases, REST is binding to distant or non-consensus sites. ChIP 
assays were performed to validate REST binding to the RE1 site on the promoters of SYNJ1 
(encoding for synaptojanin 1) and GANAB, two of the identified REST target genes in hypoxia 
(Figures 5B, D). For both SYNJ1 and GANAB, we detected REST binding to their promoters in 
hypoxia (Figure 5D). For SYNJ1, we could observe a significant recruitment of REST in hypoxia 
over normoxia. We have also investigated whether the hypoxic REST-repressed genes from our 
RNA-seq are similar to published REST ChIP-Seq datasets from 4 different cell lines 27-29. We 
found that, out of our list of 201 genes identified as REST-repressed in hypoxia, 36 were also 
REST target genes from the published ChIP-sequencing experiments (Figure 5E and 
Supplementary Table 4). This probably is still an under-estimation as there are no publically 
available REST ChIP-seq data performed on hypoxic cells. 
 
Thus our unbiased approach using RNA-Seq revealed a previously unknown aspect of REST 
repression and identifies an extensive repertoire of genes regulated by REST in hypoxia (Figure 
6), providing new insight into the mechanisms of gene repression in hypoxia. 
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Discussion 
While HIF is considered to be the master regulator of increased gene expression in hypoxia 2-4, the 
mechanisms of transcriptional repression in hypoxia are poorly understood 11. Our current study 
identifies REST as a key negative regulator of gene expression in hypoxia. We show it 
accumulates in the nucleus in response to hypoxia, and is responsible for the repression of 
approximately 20% of genes downregulated in hypoxia, thus acting as a counter-regulator to HIF-
dependent gene expression.  
 
REST is a phosphoprotein whose protein stability is tightly regulated during development. REST 
levels are reduced during neuronal development to allow the expression of REST target genes, 
while outside the nervous system, REST levels remain high to repress neuronal specific genes 
outside the nervous systems 14. REST protein was stabilised in an in vitro model of ischemia 
(typically 10 to 30 minutes of glucose/oxygen deprivation followed by re-oxygenation, typically 
for 24 hours) due to an inhibition of its degradation 30. Our pulse-chase experiments with 
cycloheximide showed that hypoxia did not affect the stability of REST. Instead, there was 
increased nuclear localisation. We also noticed that nuclear REST seemed to run at a smaller size. 
As REST is known to be phosphorylated and ubiquitylated 25, it is possible that post-translational 
modifications also control its translocation to the nucleus.  
 
Our experiments using REST siRNA in normoxic cells show that, in the basal state, only 164 
genes of the detected normoxic transcriptome (23,284 genes) are repressed by REST (equivalent to 
approximately 0.7 % of the total transcriptome detected). Of the total of genes repressed in 
hypoxia (1013), we found that 201 gene are significantly repressed by REST in hypoxia 
(equivalent to approximately 20% of the total), placing REST as a significant repressor of gene 
expression in hypoxia (Figure 6). Using qRT-PCR, we had a 38% validation rate, suggesting about 
75 of the 201 genes are expected to be bona fide REST targets in hypoxia. Furthermore, we found 
a small overlap (5 genes) between the REST-dependent genes in normoxia compared with the 
REST-dependent genes in hypoxia, indicating that REST regulates context-specific transcriptional 
networks. This has been previously described in other systems: for example REST was shown to 
regulate different target genes in neuronal stem cells versus embryonic stem cells 31, embryonic 
stem cells vs epiblast stem cells 32 and in response to ischemia in hippocampal neurons 21. The 
factors leading to this differential recruitment are only starting to be uncovered, and may involve 
different co-factors, e.g. mSin3A 32 and differences in the REST binding sequences 31,33. When we 
compared our normoxic/hypoxic REST target genes dataset with published ChIP-seq datasets, we 
found similarities of about 64% with the normoxic genes and 18% with the hypoxic genes. This 
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difference in proportions could be due to REST in hypoxia regulating more genes indirectly than 
by direct binding. This simple analysis reveals that there are layers of regulations in the control of 
gene expression and could open new research avenues into direct and indirect REST regulation. 
 
Our ChIP and qRT-PCR experiments reveal two distinct binding patterns in 2 identified REST 
target genes SYNJ1 and GANAB. While REST was bound to both of their promoters in normoxia, 
we observed significant increased binding of REST to only the SYNJ1 promoter in hypoxia. We 
propose that, while REST recruitment is correlated to gene repression in hypoxia for some REST 
target genes (e.g. SYNJ1), for other genes (e.g. GANAB) REST might be already bound to the 
target gene in a low affinity state, “poised to act,” with its repressive activity triggered only in 
hypoxia, possibly by co-factor recruitment. This is similar to the findings of Otto and colleagues 
34, which show that many of their identified REST target genes were still expressed while others 
were repressed, potentially due to their functional relevance to the cell. Interestingly SYNJ1 
encodes for synaptojanin, a protein involved in clathrin-mediated endocytosis. It could be 
speculated that this ATP-intensive process is marked for repression as soon as cellular levels of 
ATP become scarce. 
 
Our RNA-seq experiment was performed on cells in hypoxia for 24 hours (to maximise gene 
repression 8) and we did not observe as dramatic an increase in HIF and its target genes as what we 
have previously reported in cells exposed to 8 hours of hypoxia 23. Thus our experiments 
demonstrate the temporal nature of HIF signalling and its tight regulation by multiple transcription 
factors such as REST, NFκB 23,35 (which promotes HIF1A mRNA expression), or miR-155 36   
(which de-stabilizes HIF1A). Of note, our previous study showed that NFkB is recruited to the 
HIF1A promoter with maximal binding at 8 hours in hypoxia and back to normoxic level after 24 
hours 23. It is thus possible that in the absence of REST (the repressor), we see increased HIF1A 
mRNA at 8 hours, but not at 24 hours, because one of the activators NFκB is less bound, or less 
active at this particular time point. The HIF signalling network is ripe for mathematical modelling 
to unravel its regulatory pathways 37. 
 
Gene ontology analysis suggests that REST plays an important role in the cellular adaptation to 
hypoxia by supressing genes involved in proliferation (DLX5, PRKCB and MET), cell cycle 
progression (TBX3, CABLES1, ARID3A and ARAP1) and transcription, with transcription factors 
(TF) (TCF12 and LBX1), regulators of TF activity (MYCBP and ATF7IP) and general transcription 
apparatus (MMS19, CDK19 and MED12), consistent with our hypothesis that direct and indirect 
mechanisms contribute to REST gene repression in hypoxia. In addition REST also seems to 
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regulate important metabolic processes including the biosynthesis of lipids (MBOAT2, GPAM, 
PIGN, AGPS and ACACA) and nucleic acids (PARP4, SKIV2L2, PLRG1 and DHX37). 
Interestingly REST also represses genes involved in protein catabolism (FBXO18, NEDD4, 
ERLIN2 and TRIP12). Our own ChIP experiments confirmed the hypoxic regulation of SYJN1 
encoding synaptojanin 1, a protein involved in clathrin-mediated endocytosis. Thus repressing 
ATP-intensive processes in hypoxia is a plausible function for REST. Our lab has also shown a 
role for REST in the regulation of HIF-1α, and thus could impact on HIF-regulated genes as well 
23. Thus our transcriptomic analysis of hypoxic cells indicates that REST might play a key role in 
the regulation of proliferation and metabolic processes in hypoxia.  
 
Some of the REST functions may be maladaptive in cancer. For example, REST-Dependent 
repression of cell adhesion genes in hypoxia (ICAM5, ITGA8, SORBS1, LAMA4, LAMC1, LAMB1, 
COL14A1 and COL4A5) might be of importance for metastasis as hypoxic suppression of 
adhesion molecules in cancer cells has been proposed as a mechanism to allow hypoxic cancer 
cells to escape their stressed environment 38,39. Some of the previously described genes are part of 
cancer pathways (RB1, MET, MYCBP, WNT5A, HDAC1, PRKCB, LAM4A, LAMC1 and LAMB1). 
The significance of the hypoxic repression of these genes by REST will be context- and cell-
specific as REST may play both tumour suppressor and oncogenic roles, a feature it shares with 
NOTCH signalling 40, E-cadherin 41 and MYC 42. Indeed, a recent study 43 showed that knockdown 
of REST in normoxic prostate cancer cells can induce HIF signalling pathway, itself also 
implicated in cancer. In neuronal cancer, REST expression is high and has oncogenic properties by 
being anti-apoptotic and pro-tumorigenic 15,44,45. We speculate that the hypoxic microenvironment 
present in these tumours 46 could be a potential mechanism explaining REST over-expression. This 
is further supported by the observation that hypoxic neuroblastoma tumours and cells exposed to 
hypoxia (1% oxygen) down-regulate neuronal markers 47,48. REST is also implicated in stem cell 
renewal, and has been recently reported to accumulate in the nucleus of Marrow-isolated 
multilineage inducible (MIAMI) cells exposed to 3% oxygen 49.  
 
Despite being widely regarded as an activator of gene expression in hypoxia, there are a few genes 
reported to be directly repressed by HIF-1α in hypoxia (e.g. CFTR 50, ADK 51 and APC 52). Other 
examples of hypoxia-induced transcriptional repressors include DEC1 (differentially expressed in 
chondrocytes protein 1) which represses MITF (Microphthalmia-associated transcription factor) 53 
and Bach1 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) which 
represses HO-1 (heme oxygenase-1) 54. However, none of these appear to regulate as broad a 
range of genes in hypoxia as REST. Indeed, our data indicates that REST regulates 20% of genes 
12 
 
repressed in hypoxia, which may be a key and previously unappreciated feature of the hypoxic 
response. REST-repressed genes regulate biosynthetic metabolism, cell cycle and proliferation 
indicating a major role in the cellular adaptation to hypoxia. The whole set of 201 genes repressed 
in hypoxia holds exciting possibilities regarding the discovery of novel mechanisms in the hypoxic 
response mediated by transcriptional repression. In summary, our findings have identified REST 
as a key regulator underlying gene repression and cellular adaptation in hypoxia. 
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Methods 
Cell culture  
Human embryonic kidney cells (HEK-293) were cultured in Dulbecco’s modified eagle medium 
(DMEM, high glucose 4.5 g/L without pyruvate) supplemented with 10% foetal calf serum (FCS) 
and 100 U/mL penicillin-streptomycin (PS). Human non-tumorigenic mammary epithelial cells 
(MCF10A) were grown in DMEM/F12 with 5% horse serum, 100 U/mL PS, 2 mM L-Glutamine, 
10µg/mL insulin, 20ng/mL Epidermal Growth Factor (EGF), 0,5µg/mL hydrocortisone and 
100ng/ml cholera toxin. All cells were obtained from the American Type Culture Collection 
(ATCC). All reagents for cell culture were from Gibco (Life Technologies, Calrsbad, CA, USA), 
unless otherwise stated. Cells were exposed to hypoxia using pre-equilibrated media and 
maintained in standard normobaric hypoxic conditions (1% O2, 5% CO2 and 94% N2) in a hypoxia 
chamber (Coy Laboratories, Grass Lake, Michigan, USA). Normoxic controls were maintained at 
atmospheric O2 levels (21% O2, 5% CO2 and 74% N2) in a tissue culture incubator. Re-
oxygenation was performed by bringing hypoxic cells to the tissue culture incubator for the 
indicated time points. 
 
Cloning 
All reagents were from New England Biolabs (NEB) unless otherwise stated. The pRE1-TK-GLuc 
REST responsive construct was developed by incorporating the RE1 of the SCN2A gene 55 into the 
vector pTK-GLuc (NEB, N8084S). Primers were designed to amplify the RE1 using 
primerBLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). At the 5’-end of each primer 
additional nucleotides were introduced containing the restriction sites (capital letters) and 
additional nucleotides to facilitate digestion by the restriction endonucleases, a NotI restriction site 
5’-tattGCGGCCGC-3’ was introduced into the forward primer 5’- 
TTTCTCTATCGATAGGTACAGGCA -3’ and a XhoI restriction site 5’-ctattCTCGAG-3’ was 
introduced into the reverse primer 5’- GTAATTCCACTTGTGACCAGGA-3’. PCR-cloning, 
digestion, ligation and sub-cloning were performed using standard molecular biology protocols. 
The pHRE-MP-GLuc HIF responsive construct has been previously described 56. The pCMV-
CLuc construct was from NEB (N0321S, pCMV-CLuc 2). Plasmid sequencing was performed by 
MWG Eurofins, Germany. 
 
Gaussia luciferase assay, transient and stable transfections 
Gaussia luciferase assays were performed as previously described 56. Briefly, at the selected time 
points, 10 µL of media was collected from the supernatant and stored at -20°C. Gaussia luciferase 
activity was measured using the Biolux Gaussia luciferase Flex Assay kit (NEB) in a plate reader 
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(Synergy HT, Biotek) and normalized to the luciferase activity of the secreted cypridina luciferase 
under the control of a constitutive CMV promoter (pCMV-CLuc) or protein concentration. Details 
and validation of the constructs are shown in Figure S4. 
 
Cell transfection with siRNA  
Transient transfection with siControl (sc-37007, SCB) and siREST (s11932, Life Technologies) 
were performed as previously described 57. Transfections with siRNA to be used in luciferase 
assays were performed in 24 well plates, as described above. All other experiments were 
performed on 6 well plates unless otherwise stated. In a typical experiment 200 K cells were 
seeded on 6 well plates and allowed to grow until approximately 60 % confluent, at this time cells 
were transfected with 2 μL of Lipo, 100 μL Optimem and a pre-optimized amount of 
overexpressing construct (100 ng) or siRNA (100 pmol). On the day after transfection, cells were 
exposed to hypoxic or normoxic media. Transfection time with siRNA was kept constant for all 
experimental conditions. For RNA extraction experiments, siRNA was incubated for 48 hrs. For 
the preparation of whole cell protein extracts, siRNA was incubated for 72 hrs.  
 
Cycloheximide (CHX) pulse chase experiments 
For the experiments where CHX-pulse chase was used to determine the protein stability of HIF-
1α, REST and β-Actin in normoxia and hypoxia, 750,000 HEK293 cells where seeded on 6 cm 
dishes. The following day cells where conditioned to 24 hours of hypoxia or normoxia, after which 
cells where subjected to a pulse-chase treatment of cycloheximide (5µg/mL) to block translation, 
and address the stability of the proteins in normoxia and hypoxia. Time points of CHX treatment 
after normoxic or hypoxic incubation included 0, 1, 2, 4, 8, 24 and 48 hours. 
 
qRT-PCR 
cDNA was synthesized from 1 µg of RNA using MMLV (Promega), and amplified using the 
Prism 7900HT sequence detection system (Applied Biosystems, Foster City, CA) under default  
conditions. The mRNA relative expression was calculated by the ∆∆Ct method by normalizing the 
Ct of the samples to that of 18S rRNA (TaqMan Universal PCR Master Mix with the primer 18S 
rRNA-Euka, 4310893E, Life Technologies), followed by normalization to the control condition. 
The following REST qRT-PCR primers were used: 
F: CGCCAGAGGGTGAAACTTTA; R: ATCCACAGCCATGAAGGAAG 
 
Western blot 
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All reagents were from Sigma unless otherwise stated. Standard protocols were used as previously 
described 57,58. Mouse anti-β-actin, 1:10000, Sigma, A5441; Mouse anti-HIF-1α,1:1000, BD 
Pharmingen, 610958; Rabbit anti-REST, 1:1000, Abcam, ab28018; Rabbit anti-Lamin A/C, 
1:1000, Cell Signalling, 2032; Mouse anti-α-Tubulin, 1:2000, SCB, sc-8035. 
 
ChIP assays 
ChIP assays where performed as previously described 59. 
The following ChIP qRT-PCR primers were used: 
SYNJ1, F: TCCAGACACTCAGACTAGGAACTC, R: CCTGAAGAGCTGTCCATGGT, Probe: 
CCGTTTGCTGGGCTGTCGAC. 
The following antibodies were used: 
Rabbit REST, 2 µg, Millipore, Rabbit IgG, 5 µg, Millipore, PP64B. 
 
Cell death using flow cytometry (YO-PRO and PI stains) and trypan blue exclusion assays. 
Trypan Blue (Sigma), was added 1:1 V/V to the cells, and live/dead cells where counted in an 
haemocytometer, by counting the Trypan blue permeabilised cells (dead), and the bright cells 
(alive), that where not Trypan Blue permeabilised. Data is represented as a percentage of the total 
population. Flow Cytometry staining to detect live and dead cells (early, late and end stage 
apoptotic cells) was performed using standard protocols. Briefly, cells where detached with 
Accutase solution, and stained with PI/YO-PRO, and counted in an Accuri C6 cytometer. Results 
are shown as the percentage of the total population under each condition. 
 
REST mRNA expression profiling 
Human REST mRNA expression level according to anatomical distribution, or in different cell 
lines, was compiled from publically available microarray datasets using the Genevestigator 
software (https://genevestigator.com/gv/). 
 
RNA sequencing  
HEK293 (100 thousand cells) were seeded on 6 well plates, transfected the next day with REST-
RNAi or Ctrl-RNAi in 1 µL of Lipofectamine 2000. In the day after transfection cells were 
exposed to 1% oxygen using pre-conditioned media for 24 hours. RNA was isolated using QIAgen 
RNeasy columns as per supplier instructions. Total RNA electropherograms were used to evaluate 
RNA integrity, with integrity number for all samples being of the highest quality, RIN=10, before 
being sent to the sequencing facility. Library construction began with 1 µg of total RNA.  Since 
the protocol utilized was based on polyA capture, RNA was visualized on a BioRad Experion to 
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insure RNA Quality Index values were greater than 8.  For library construction the Illumina 
TruSeq v2 mRNA kit was utilized. This included also the poly(A)+ RNA isolation and DNase 
treatment.  The protocol was followed according to manufacturer’s instructions except the final 
number of PCR cycles was 12 and not 15. Fifty base pare single end reads were prepared.  
Following construction, libraries were visualized by Bioanalyzer (Agilent) using the High 
Sensitivity Chip and quantified for pooling and sequencing using Kapa Biosystems qPCR 
quantitation kit according to manufacturer’s instructions. For sequencing libraries were diluted to 
16 pM then applied to a V3 flowcell using the Illumina cBot according to manufacturer’s 
instructions. Sequencing was carried out on the Hi-Seq 2000 using HSCS v 1.5.15.1.  Image 
analysis and base calling were carried out using RTA 1.13.48.0, and deconvolution and fastq file 
production were performed with CASAVA 1.8.2. Quality control metrics were obtained with 
Picard after Illumina FASTQ files alignment to the human genome hg19 reference sequence 
(GRCh37) using TopHat v2.0.8b 60. Raw sequencing files and derived alignment files data are 
available in the ArrayExpress database (https://www.ebi.ac.uk/arrayexpress/) under the accession 
number E-MTAB-2580. 
 
RNA sequencing bioinformatics analysis 
Illumina FASTQ files were aligned to the human genome hg19 reference sequence (GRCh37) 
using TopHat v2.0.8b 60  (including Bowtie 2.1.0.0 and Samtools 0.1.19.0) with the -no-coverage-
search option and the -G option to use a transcriptome index computed from the UCSC hg19 
genes.gtf annotation. Transcript abundance and differential expression was estimated by direct 
comparison of normalized transcript counts from pairs of experimental conditions using the 
Cufflinks Cuffdiff2 program (v2.1.1) 61  with default options and the UCSC hg19 genes.gtf 
annotation. To control for false positives, a second estimate of gene expression was computed 
using the HTSeq-count script (v0.6.1; 62 followed by differential expression analysis with the 
Bioconductor edgeR package (v3.6.1) 63, which uses a generalized linear model likelihood ratio 
test. Benjamini and Hochberg's algorithm is used to control the false discovery rate (FDR) due to 
multiple testing 64 , those genes with FDR (q-value) < 0.05 were considered differentially 
expressed. The February 2009 human reference sequence (GRCh37) was produced by the Genome 
Reference Consortium (http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/). 
 
Analysis of the promoter of REST-Dependent hypoxia repressed genes 
Genomic sequences of genes identified as differentially regulated ("REST-Dependent genes 
repressed in hypoxia") were extracted from the USCS Genome Browser database, selecting 2000 
bases upstream (5') of the transcriptional start site (TSS) and 1000 bases 3' of the TSS. When 
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multiple TSS sites were annotated for a single gene, the 3Kb region was selected for all of them. 
The motif for the RE1 site from the JASPAR database (MA0138.2) was used as a frequency 
matrix and compared to the 3Kb sequences by the pssm.search method using the Biopython 
Bio.motifs module, with a pseudocount of 0.5 and Normal background (equal frequency of 
G:A:T:C bases). The log odds threshold was set to 15, which would yield an expected false 
positive rate of approximately 0.05 against random background sequences. The sensitivity of this 
method was calibrated against equal sized sets of 3Kb random sequences (using RSA-Tools) and 
against the target sequences with the RE1 motif bases shuffled (using EMBOSS).  
 
We found 12 high stringency RE1 motifs (log odds score of 15) in the promoter region (-
2Kb/+1Kb) of REST-dependent genes repressed in hypoxia (Figure 6B). This number of hits is 
much higher than what could be found in control experiments, when the RE1 motif was searched 
against an equal sized set of random sequences (2.4 ± 0.54 gene hits, Figure 6C) or randomly 
shuffling the promoter sequences from the REST genes (0.4 ± 0.54 gene hits, Figure 6C). This 
analysis strengthen the point that the REST-dependent genes repressed in hypoxia have consensus 
RE1 motifs in the -2Kb/+1Kb region of their promoter in a greater frequency than one would 
expect by chance. 
 
Functional analysis of gene datasets using PANTHER and DAVID 
PANTHER was used for the functional annotation of gene lists (Figures S1A-J) and for the 
statistical overrepresentation tests (Figures 1C-H), significance threshold was set as p<0.05 for the 
binomial test 65,66. This is a hypergeometric test which first assigns each gene to one or more GO 
or PANTHER categories, and then tests if there are more genes in a particular category than those 
one would expect by random chance in a dataset of similar size.  DAVID Functional Annotation 
Clustering was performed with default settings, the significance threshold of this gene-enrichment 
analysis was set as p<0.05 for the EASE Score (a modified Fisher Exact p-Value) 67,68.  
 
Statistical analysis 
All experiments were performed at least 3 independent times. Data is shown as mean ± SEM. 
Statistical significance was tested in Prism (Graphpad), using Student’s t test for the comparison of 
two data sets or ANOVA for more than two datasets. * p < 0.05, ** p < 0.01 and *** p < 0.001. 
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Figure legends 
 
Figure 1. Hypoxia induced gene expression changes assessed by genome wide 
sequencing. (A) Volcano plot showing changes in gene expression due to hypoxia (1% O2) 
plotted against significance. Each dot represents the mean fold change for a single gene with 
induced genes as green dots, repressed as red and unchanged as black. Horizontal blue dashed 
line indicates q<0.05. Cells were treated with Ctrl_RNAi before hypoxia exposure and RNA-
seq. (B) Mean fold change values for well described hypoxia induced (green bars) and 
repressed genes (red bars). (C, D) Enriched GO Biological processes.  
 
Figure 2. REST is a hypoxia sensitive transcription factor. (A) REST mRNA expression 
compiled from publically available microarray datasets of different tissues and cell lines. The 
graph was compiled with Genevestigator and shows the human REST mRNA expression 
levels (xx axis) and number of samples (yy). HEK293 cells were exposed to hypoxia (1% O2) 
for the indicated time points, nuclear extracts (B), cytoplasmic (D) and whole cell extracts (F) 
were prepared and immunoblotted as indicated for REST, HIF-1α, Lamin A/C (nuclear 
marker) and α-Tubulin (cytoplasmic marker) (n = 4-5). (C, E, G) Densitometric analysis of 
B, D and F, respectively. (H) HEK293 cells where exposed to hypoxia (1% O2) for 16 hours 
followed by re-oxygenation (21% O2) for 1 and 16 hours, cytoplasmic and nuclear extracts 
where prepared and immunoblotted as indicated (N=4). (I) Cells were transfected with a 
vector expressing Gaussia luciferase under the control of the TK promoter (pTK-GLuc) for 
constitutive expression, or with the REST responsive pRE1-TK-GLuc construct. REST 
repressor activity = RLU pTK-GLuc / RLU pRE1-TK-GLuc (N=3). (J) HEK293 cells were exposed to 
hypoxia (1% O2) for the indicated time points, mRNA was collected and analysed by qRT-
PCR, n = 6-10. Data are represented as mean ± SEM. * =  p<0.05, ** = p<0.01, significant 
fold change over 21% O2. 
 
Figure 3. REST regulates hypoxia repressed genes. (A) Overview of the RNA-seq 
approach used to reveal the contribution of REST to gene repression in hypoxia. (B) REST 
mRNA expression from the 3 independent RNA-seq experiments after treatment with 
hypoxia or REST-RNAi treatment. (C) REST-RNAi treatment on cells exposed to normoxia 
(21% oxygen) for 24 hours led to a significant increase in the expression of well-
characterised REST target genes (shown as Cuffdiff mean fold changes (log base 2) of 3 
independent experiments). (D) RNA-Seq analysis revealed 201 REST-Dependent genes 
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(Red) among the repressed genes (Blue). Data shown as a Volcano plot showing changes in 
gene expression due to hypoxia (1% O2) plotted against significance. Only genes with 
statistically significant fold changes are shown. Each dot represents the mean fold change for 
a single gene with induced-genes as green dots (“Hypoxia induced”), repressed-genes as blue 
(“Hypoxia repressed”), and the genes that were not repressed by hypoxia in the presence of 
siRNA against REST shown as red dots (“REST-Dependent”). (E) Heat-map showing genes 
repressed by hypoxia (left column, Ctrl-RNAi), that where not repressed upon REST-RNAi 
treatment (right column, REST-RNAi). Data is presented as fold change to hypoxia of the top 
20 genes most repressed by hypoxia among the REST-dependent genes. (F) Summary of the 
gene clusters found to be uniquely repressed by REST-Independent mechanisms (Blue), 
REST-Dependent mechanisms (Red) and the common clusters between the two mechanisms 
(Grey). Clusters were obtained using DAVID Functional Annotation Clustering together with 
manual curation of the results. For a detailed description of the annotation terms and gene 
groups associated with each cluster see Table S2. 
 
Figure 4. REST regulates different transcriptional networks in normoxia and hypoxia. 
(A) There is limited overlap (5 genes) between REST-Dependent genes repressed in 
normoxia (164, dark circle) and REST-Dependent genes repressed in hypoxia (201, red 
circle). Circular diagrams show the distribution of enriched GO biological processes by 
PANTHER overrepresentation test. Significance was set at p<0.05. The top 20 genes by fold-
change upon REST-RNAi treatment for the REST-Dependent genes repressed in normoxia 
(B) and REST-dependent genes repressed in hypoxia (C) are shown. (D, E) qRT-PCR was 
used to validate the mRNA expression of the REST target genes RAB3C and CYP1B1 in cells 
exposed for 24 hours to normoxia (21% oxygen) or hypoxia (1% oxygen), in the presence or 
absence of an siRNA targeting REST. (F) Of the 851 genes induced in hypoxia (blue circle), 
29 where further induced by REST siRNA treatment. Circular diagrams show the distribution 
of enriched GO biological processes by PANTHER overrepresentation test. 
 
Figure 5. REST represses genes in hypoxia by direct binding to an RE1 site on their 
promoter regions.  (A) Consensus RE1 binding site (JASPAR matrix representation). (B) 
Identification of 12 high stringency RE1 sites in the in the proximal promoter (-2000 bp to 
+1000 bp kilobase) of REST-dependent hypoxia repressed genes. (C) The number of RE1 
sites identified by our informatics analysis is compared to the number of RE1 sites that could 
be expected by random chance (see Materials and Methods for details. Data is presented as 
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mean ± SD. Error bars represent the SD from the 500 simulations. (D) ChIP assay for REST 
binding in normoxia and hypoxia (24 hours) to the RE1 found in the proximal promoter of 
the GANAB and SYNJ1 gene. (E) Overlap between the number of genes identified to be 
REST target genes in normoxia or hypoxia, with the REST target genes identified by ChIP-
seq in published datasets. Data is represented as mean ± SEM. * = p<0.05, significant over 
normoxic control and IgG. n.d.= none detected, for some of the biological replicates. 
 
Figure 6. REST is a master regulator of gene repression in hypoxia and regulates 
different transcriptional networks depending on oxygen availability. Our analysis 
showed that REST repressed 20% of the hypoxia-repressed genes, and only 0.7% of all genes 
repressed in normoxia. Furthermore there is only a limited overlap between the 2 
transcriptional networks (5 genes), and most of the genes repressed by REST in normoxia are 
still repressed by REST under hypoxia. Thus, rather than a shift on the transcriptional 
repertoire of REST target genes from normoxia to hypoxia, we show that there is a 
recruitment to new target genes in hypoxia. 
 
 
 
 
 
 






